Latest Xaira Therapeutics News & Updates

See the latest news and media coverage for Xaira. We track all announcements, press releases, and industry mentions in real time, all in one place.

Xaira Therapeutics (Xaira)

AI-powered therapeutics discovery and development company

xaira.com

Headquarters: South San Francisco, United States
Founded year: 2023
Company type: Private company
Number of employees: 200–220
Industry: Pharmaceuticals

Last updated June 22

Latest news about Xaira Therapeutics (Xaira)

In short: Xaira advanced AI-driven drug discovery, unveiling its virtual cell model X-Cell and antibody platform.

Company announcements

March 26 Xaira

Xaira appoints Rachel Lane as SVP of Business Development and Operations

The biotech firm names Dr. Lane to lead business development and operations roles effective March 26, 2026.

March 25 Xaira

Xaira launches AI in Residence program

It targets recent MS/PhD graduates for 6-12 month projects advancing models like X-Cell. Applications are now open.

March 17 Xaira

Xaira launches X-Cell virtual cell model

X-Cell is trained on the largest genome-wide perturbation dataset and predicts unseen experiment outcomes. It aims to transform drug discovery.

October 1, 2025 Xaira

Xaira discusses AI moonshot in biomedicine

Bo Wang, SVP & Head of Biomedical AI at Xaira, joins Endpoints News #AIDay2025 to separate hype from reality and highlight future directions for biomedicine.

Media coverage

June 22 BioSpace

Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in

About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the...

March 26 01net

Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations

Biotech industry veteran and former Chief Business Officer at Belharra Therapeutics joins Xaira to help scale partnerships for its AI-enabled drug discovery platformSOUTH SAN FRANCISCO...

March 23 American City Business Journals

Xaira Therapeutics raised nearly $1 billion. Here's its next act

Funders committed nearly $1 billion toward this AI company. Here's its next act.

March 20 FierceBiotech

Behind the curtain: What Xaira is building after its $1B fundraise

Since Xaira's eye-popping $1 billion fundraise in 2024, the company has said relatively little in public. | What has Xaira been doing since its $1...

Never miss news about Xaira

Track Xaira and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Xaira competitors & trending companies

Browse news for competitors to Xaira and other trending companies.